[ClickPress, Thu Sep 27 2018] According to the new market research report " Defibrillators Market by Product (Implantable Cardioverter Defibrillator (Transvenous ICD, Single & Dual Chamber, CRT-D, S-ICD) and External (Manual, AED, Wearable)), End User (Hospitals, Prehospital, Public Access, Home care) - Global Forecast to 2022" , published by MarketsandMarketsao, the market is projected to reach USD 10.88 Billion by 2022 from USD 9.32 Billion in 2017, growing at a CAGR of 3.1%.
Studies were identified searching PubMed from the start of the database until the end of 2017 using the term "wearable cardioverter defibrillator" or "wearable cardioverter-defibrillator" and "wcd." Only English-written articles were considered.
Arecent study showed that people who have pacemakers or implantable cardioverter defibrillators (ICDs) to treat atrial fibrillation or atrial tachycardia (AT/AF) have no higher risk of stroke from short (less than 20 seconds) bouts of atrial fibrillation (AF) than people who have no AF.
VIENNA -- Psychiatric assessment of 82 Turkish patients who had received implantable cardioverter defibrillators showed that the recipients had a high prevalence of sexual dysfunction, posttraumatic stress disorder, major depressive disorder, panic disorder, and generalized anxiety disorder, Dr.